Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pul… Read more
Neuronetics Inc (STIM) - Total Liabilities
Latest total liabilities as of September 2025: $114.11 Million USD
Based on the latest financial reports, Neuronetics Inc (STIM) has total liabilities worth $114.11 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Neuronetics Inc - Total Liabilities Trend (2016–2024)
This chart illustrates how Neuronetics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Neuronetics Inc Competitors by Total Liabilities
The table below lists competitors of Neuronetics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nevada King Gold Corp
OTCQB:NKGFF
|
USA | $86.64K |
|
Funkwerk AG
F:FEW
|
Germany | €70.25 Million |
|
Greenland Resources Inc
PINK:GRLRF
|
USA | $548.47K |
|
Tainan Enterprises Co Ltd
TW:1473
|
Taiwan | NT$1.35 Billion |
|
Betmakers Technology Group Ltd
PINK:TPBTF
|
USA | $38.93 Million |
|
Entech SE SAS
PA:ALESE
|
France | €49.43 Million |
|
Lihtai Construction Enterprise Co Ltd
TWO:5520
|
Taiwan | NT$1.21 Billion |
|
Handok
KO:002390
|
Korea | ₩536.54 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Neuronetics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Neuronetics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Neuronetics Inc (2016–2024)
The table below shows the annual total liabilities of Neuronetics Inc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $109.10 Million | +33.64% |
| 2023-12-31 | $81.64 Million | +36.47% |
| 2022-12-31 | $59.82 Million | +6.74% |
| 2021-12-31 | $56.05 Million | +5.42% |
| 2020-12-31 | $53.16 Million | +1.62% |
| 2019-12-31 | $52.32 Million | +13.78% |
| 2018-12-31 | $45.98 Million | -80.15% |
| 2017-12-31 | $231.59 Million | +14.69% |
| 2016-12-31 | $201.92 Million | -- |